Peter V. Danenberg

10.8k citations

154 papers · 7.9k indexed · 3 hit papers · h-index 47

Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 37
Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 15
- Cancer Genomics and Diagnostics 14
Pathology and Forensic Medicine top 1%
- Genetic factors in colorectal cancer 21
Pulmonary and Respiratory Medicine top 1%
- Gastric Cancer Management and Outcomes 16
Molecular Biology top 1%
- Biochemical and Molecular Research 26
- RNA modifications and cancer 14
Surgery
- Esophageal Cancer Research and Treatment 18

Co-authors: Kathleen D. Danenberg Jan Brabender Heinz‐Josef Lenz Reginald V. Lord Dennis Salonga Charles Heidelberger Ralf Metzger Arnold Lockshin
Cited by: Oncology Cancer Research Pathology and Forensic Medicine
Journals: Clinical Cancer Research (9 papers)Journal of Medicinal Chemistry (9 papers)Journal of Gastrointestinal Surgery (8 papers)
Partner nations: United States Germany Japan

In The Last Decade

Peter V. Danenberg

149 papers receiving 7.6k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2002 PubMed
2001 Journal of Clinical Oncology
1977 Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Peers

Countries citing papers authored by Peter V. Danenberg

Since Specialization

Citations

This map shows the geographic impact of Peter V. Danenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter V. Danenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter V. Danenberg more than expected).

Fields of papers citing papers by Peter V. Danenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter V. Danenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter V. Danenberg. The network helps show where Peter V. Danenberg may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter V. Danenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter V. Danenberg Line = papers co-authored together Peter V. Danenberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Patient-centered developments in colon- and rectal cancer with a multidisciplinary international team: From translational research to national guidelines World Journal of Gastrointestinal Surgery ·Karl-Heinrich Link,Marko Kornmann,Ludger Staib,Meli Br Sembiring Meliala,Wilhelm Gaus,E. Röttinger,Izzi Benedetta,Abdelkebir Sahid,Peter V. Danenberg,Kathleen D. Danenberg,Lv Ding,Silvia Sander,Zhenling Ji,Jiangtao Li,Shu-you Peng,R. Bittner,Hans G. Beger,Benno Traub	2021	2
2	MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy Neoplasia ·Andreas-Claudius Hoffmann,Peter J. Wild,Marta Klopocka,Simone Bertz,Kathleen D. Danenberg,Peter V. Danenberg,Robert Stöhr,Michael Stöckle,Jan Lehmann,Martin Schüler,Arndt Hartmann	2010	106
3	Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review European Archives of Oto-Rhino-Laryngology ·Ochsner Nick,Peter V. Danenberg	2010	20
4	Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer. PubMed ·Rintaro Mori,Qingcai Wang,Marcus L. Quek,Z. Głodowski,Eric Cheung,Ye Wei,Susan Groshen,Debra Hawes,Shinji Togo,Hiroshi Shimada,Kathleen D. Danenberg,Peter V. Danenberg,Jacek Pinski	2008	8
5	Messenger RNA Expression of Vascular Endothelial Growth Factor and Its Receptors in Primary Colorectal Cancer and Corresponding Liver Metastasis Annals of Surgical Oncology ·Hirotoshi Kobayashi,Kenichi Sugihara,Hiroyuki Uetake,Tetsuro Higuchi,Masamichi Yasuno,Masayuki Enomoto,Hidekazu Kuramochi,Heinz‐Josef Lenz,Kathleen D. Danenberg,Peter V. Danenberg	2008	7
6	High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1 Cancer Chemotherapy and Pharmacology ·Hidekazu Kuramochi,Kazuhiko Hayashi,Yuusuke Uchida,Go Nakajima,Takashi Hatori,Kathleen D. Danenberg,Peter V. Danenberg,Masakazu Yamamoto	2008	20
7	Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine BMC Cancer ·Yuusuke Uchida,Peter V. Danenberg,Kathleen D. Danenberg,Jean L. Grem	2008	33
8	5‐fluorouracil‐related gene expression levels in primary colorectal cancer and corresponding liver metastasis International Journal of Cancer ·Hidekazu Kuramochi,Kazuhiko Hayashi,Yuusuke Uchida,S. Wiener,Daisuke Shimizu,Daniel Vallböhmer,Seong-Jin Park,Kathleen D. Danenberg,Ken Takasaki,Peter V. Danenberg	2006	32
9	Antireflux Surgery Normalizes Cyclooxygenase-2 Expression in Squamous Epithelium of the Distal Esophagus The American Journal of Gastroenterology ·Daniel Vallböhmer,Steven R. DeMeester,Daniel Oh,Farzaneh Banki,Hidekazu Kuramochi,Daisuke Shimizu,Jeffrey A. Hagen,Kathleen D. Danenberg,Peter V. Danenberg,Parakrama Chandrasoma,Jeffrey H. Peters,Tom R. DeMeester	2006	23
10	Sex Differences in the Predictive Power of the Molecular Prognostic Factor HER2/neu in Patients with Non–Small-Cell Lung Cancer Clinical Lung Cancer ·Daniel Vallböhmer,Jan Brabender,Dongyun Yang,Kathleen D. Danenberg,Paul M. Schneider,Ralf Metzger,Arnulf H. Hölscher,Peter V. Danenberg	2006	25
11	Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer Journal of the American College of Surgeons ·Sylke Schneider‐Burrus,Yuusuke Uchida,Jan Brabender,Stephan Baldus,O Maalmali,Kathleen D. Danenberg,Dennis Salonga,Pei Chen,Denice Tsao‐Wei,Susan Groshen,Arnulf H. Hoelscher,Paul M. Schneider,Peter V. Danenberg	2005	52
12	Molecular Predictors of Lymph Node Metastasis in Colon Cancer: Increased Risk With Decreased Thymidylate Synthase Expression Journal of Gastrointestinal Surgery ·Avo Artinyan,Rahila Essani,J P Lake,Andreas M. Kaiser,Gianluca Coletti,Peter V. Danenberg,Kathleen D. Danenberg,Robert W. Haile,Robert W. Beart	2005	7
13	Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer International Journal of Radiation OncologyBiologyPhysics ·Silvia C. Formenti,Darcy Spicer,Kristin A. Skinner,Carlos Rochester Ferreira de Lima,Susan Groshen,Anna Bettini,Wesley Y. Naritoku,Michael F. Press,Dennis Salonga,Denice Tsao‐Wei,K. D. Danenberg,Peter V. Danenberg	2002	32
14	Functional Polymorphism of the Thymidylate Synthase Gene in Colorectal Cancer Accompanied by Frequent Loss of Heterozygosity Japanese Journal of Cancer Research ·Kazuyuki Kawakami,Yoshinori Ishida,Kathleen D. Danenberg,Kenji Omura,Go Watanabe,Peter V. Danenberg	2002	52
15	Glutathione S–Transferase-Pi Expression Is Downregulated in Patients With Barrett's Esophagus and Esophageal Adenocarcinoma Journal of Gastrointestinal Surgery ·Jan Brabender,Reginald V. Lord,Kumari Wickramasinghe,Ralf Metzger,Paul M. Schneider,Jimin Park,Arnulf H. Hölscher,Tom R. DeMeester,Kathleen D. Danenberg,Peter V. Danenberg	2002	41
16	Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy Cancer Letters ·Marko Kornmann,Karl H. Link,Heinz‐Josef Lenz,J. Pillasch,Ralf Metzger,Ferry Mahulette,Gerhard Leder,Eun-Gil Kim,F. Safi,Kathleen D. Danenberg,Magnus Larsson,Peter V. Danenberg	1997	77
17	Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-Fluorouracil and radiation therapy International Journal of Radiation OncologyBiologyPhysics ·Silvia C. Formenti,Gary L. Dunnington,Jeremy Goverman,Heinz Josef Lenz,Katеryna Dumanska,Howard Silberman,Darcy Spicer,Т.М. Яблонська,M. Soskin,Susan Groshen,Kristy Watkins,Franco M. Muggia,Barbara D. Florentine,Michael F. Press,Kathleen D. Danenberg,Peter V. Danenberg	1997	47
18	Gene amplification and multidrug resistance induced by the phosphatase-inhibitory tumor promoter, okadaic acid Carcinogenesis ·Karmilawati Kadir,R.D. Scavetta,Heinz-Josef Lenz,Kathleen D. Danenberg,Peter V. Danenberg,Axel H. Schönthal	1995	16
19	Inactivation of Tetrahymena rRNA self-splicing byc/s-platin proceeds through dissociable complexes Nucleic Acids Research ·Peter V. Danenberg,W. Rozczynialski,Kathleen D. Danenberg,Tetsuro Horikoshi	1991	10
20	Synthesis and interaction with uridine phosphorylase of 5'-deoxy-4',5-difluorouridine, a new prodrug of 5-fluorouracil Journal of Medicinal Chemistry ·Nelson Mbulahaeni Musehane,Ashok R. Bapat,Peter V. Danenberg,Ewerton Leonardo Da	1988	22

About Peter V. Danenberg

Peter V. Danenberg is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 154 papers that have together received 7.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (37 papers), Biochemical and Molecular Research (26 papers), Genetic factors in colorectal cancer (21 papers), Esophageal Cancer Research and Treatment (18 papers), Gastric Cancer Management and Outcomes (16 papers), Cancer, Hypoxia, and Metabolism (15 papers), Cancer Genomics and Diagnostics (14 papers) and RNA modifications and cancer (14 papers). The work is most often cited by research in Oncology (3.8k citations), Cancer Research (1.5k citations), Pathology and Forensic Medicine (1.1k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Molecular Biology (4.0k citations). Peter V. Danenberg has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Kathleen D. Danenberg, Jan Brabender, Heinz‐Josef Lenz, Reginald V. Lord, Dennis Salonga, Charles Heidelberger, Ralf Metzger, Arnold Lockshin, Susan Groshen and Paul M. Schneider. Their work appears in journals such as Clinical Cancer Research, Journal of Medicinal Chemistry, Journal of Gastrointestinal Surgery, Biochemistry and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact